Skip to main content
![Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [<sup>177</sup>Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine](https://jnm.snmjournals.org/sites/default/files/styles/medium/public/externals/464cf386854f243139889cb0ba0cee7c.jpg?itok=abLuSIyM)